Congratulations to @TraceNeuro on their launch with a $101M Series A! We are excited to support a team on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases.
1 in 400 people around the world will be diagnosed w/ #ALS in their lifetime. Meet Trace - on a mission to expand the promise of genomic medicine for those w/ neurodegenerative diseases, re-establishing healthy communication between nerves & muscle cells. businesswire.com/news/home/2024…View quoted post on X